Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.

Itani, Kamal M F; Akhras, Kasem S; Stellhorn, Robert; Quintana, Alvaro; Budd, David; Merchant, Sanjay

Itani, Kamal M F; Akhras, Kasem S; Stellhorn, Robert; Quintana, Alvaro; Budd, David; Merchant, Sanjay.

Affiliation

Itani KM; Veterans Administration Boston Health Care System and Boston University, Boston, Massachusetts, USA. kitani@med.va.gov

Pharmacoeconomics ; 27(5): 421-30, 2009.

Article in En | MEDLINE | ID: mdl-19586079

Subject(s)

Health Care Costs/statistics & numerical data; Skin Diseases, Bacterial/drug therapy; Vancomycin/administration & dosage; Vancomycin/economics; Anti-Bacterial Agents/administration & dosage; Cohort Studies; Databases as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Length of Stay/economics; Length of Stay/statistics & numerical data; Male; Methicillin-Resistant Staphylococcus aureus/drug effects; Middle Aged; Retreatment; Skin Diseases, Bacterial/economics; Skin Diseases, Bacterial/mortality; Staphylococcal Skin Infections/drug therapy; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Health Care Costs / Skin Diseases, Bacterial Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google